Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Accenture
Julphar
Moodys
Chinese Patent Office
QuintilesIMS
Citi
AstraZeneca
McKesson
Medtronic

Generated: January 21, 2018

DrugPatentWatch Database Preview

NEOMYCIN SULFATE-POLYMYXIN B SULFATE-HYDROCORTISONE Drug Profile

« Back to Dashboard

Which patents cover Neomycin Sulfate-polymyxin B Sulfate-hydrocortisone, and when can generic versions of Neomycin Sulfate-polymyxin B Sulfate-hydrocortisone launch?

Neomycin Sulfate-polymyxin B Sulfate-hydrocortisone is a drug marketed by Pharmafair and is included in two NDAs.

The generic ingredient in NEOMYCIN SULFATE-POLYMYXIN B SULFATE-HYDROCORTISONE is hydrocortisone; neomycin sulfate; polymyxin b sulfate. There are sixty-four drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the hydrocortisone; neomycin sulfate; polymyxin b sulfate profile page.
Summary for NEOMYCIN SULFATE-POLYMYXIN B SULFATE-HYDROCORTISONE
Drug patent expirations by year for NEOMYCIN SULFATE-POLYMYXIN B SULFATE-HYDROCORTISONE

US Patents and Regulatory Information for NEOMYCIN SULFATE-POLYMYXIN B SULFATE-HYDROCORTISONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmafair NEOMYCIN SULFATE-POLYMYXIN B SULFATE-HYDROCORTISONE hydrocortisone; neomycin sulfate; polymyxin b sulfate SOLUTION/DROPS;OTIC 062394-001 Sep 29, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmafair NEOMYCIN SULFATE-POLYMYXIN B SULFATE-HYDROCORTISONE hydrocortisone; neomycin sulfate; polymyxin b sulfate SUSPENSION/DROPS;OPHTHALMIC 062623-001 Sep 24, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Chinese Patent Office
Accenture
Queensland Health
Fish and Richardson
Express Scripts
UBS
McKinsey
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot